Sterling Biotech reports standalone net loss of Rs 91.85 crore in the March 2016 quarter

Sales rise 12.41% to Rs 113.12 crore

Net Loss of Sterling Biotech reported to Rs 91.85 crore in the quarter ended March 2016 as against net loss of Rs 90.35 crore during the previous quarter ended March 2015. Sales rose 12.41% to Rs 113.12 crore in the quarter ended March 2016 as against Rs 100.63 crore during the previous quarter ended March 2015.

For the full year,net loss reported to Rs 468.69 crore in the year ended March 2016 as against net loss of Rs 457.71 crore during the previous year ended December 2014. Sales declined 21.43% to Rs 523.99 crore in the year ended March 2016 as against Rs 666.95 crore during the previous year ended December 2014.

ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Dec. 2014% Var.Sales113.12100.63 12 523.99666.95 -21 OPM %15.1813.07 -13.8012.53 - PBDT-65.73-63.24 -4 -342.48-385.92 11 PBT-135.96-133.74 -2 -693.80-662.49 -5 NP-91.85-90.35 -2 -468.69-457.71 -2

Powered by Capital Market - Live News